Federal drug safety reviewers are backing off threats to force a recall of midrodine, which is marketed as ProAmantine, indicating that they will give the manufacturers of the low blood pressure…
Tag Archives: ProAmantine
The FDA is proposing to remove drug approval for the low blood pressure drug ProAmantine and its generics, which would result in a ProAmantine recall from the market.
More Top Stories
The new federal judge overseeing all talcum powder lawsuits has called for a Science Day to educate the court ahead of planned Daubert hearings which could decide if bellwether test trials can move forward.
Plaintiffs filing Tepezza hearing loss lawsuits claim Horizon Therapeutics, the manufacturer, knew for years that the thyroid eye disease was linked to widespread reports of hearing problems.
The U.S. government has outlined requirements for qualifying for Camp Lejeune elective option settlement offers.